Episurf Medical strengthens the company’s management group which will consist of the following members with their respective responsibilities:
Pål Ryfors – Acting CEO and CFO
Ladan Amiri – Head of Quality & Regulatory Affairs
Dan Griffiths – Marketing Director
Göran Martinsson – Sales Director
Jeanette Spångberg – COO
These changes will be effective April 10. With exception of Pål Ryfors who has been a member of the management group since 2015 and Jeanette Spångberg who has been a member of the management group since 2011.
“We must create a team that matches the quality of our technology, and I think we are doing just that. I look forward towards creating shareholder value together with this group and the individuals have knowledges and experiences which are crucial to Episurf Medical”, says Pål Ryfors, acting CEO and CFO.
Ladan Amiri was employed by Episurf Medical in August 2015 and has more than 20 years of experience from the medical technology industry and areas such as product development, risk management and the quality and regulatory areas on a global basis. Prior to joining Episurf Medical, Ladan worked at companies such as RaySearch Laboratories, St Jude Medical, Maquet and Siemens.
Dan Griffiths was employed by Episurf Medical in April 2016 and has 19 years of experience from the orthopeadic industry from companies such as Zimmer and Lima Corporation where he has held a number of senior positions within the marketing and sales organizations with a large focus towards the knee product portfolios.
Göran Martinsson was employed by Episurf Medical in August 2014. He has more than 30 years of experience from senior management roles in various technology companies on a global basis, including companies in the medical technology sector. Prior to joining Episurf Medical Göran worked at companies such as ArthroCare and Merivaara.
The recruitment process for a permanent CEO is ongoing.
For more information, please contact:
Pål Ryfors, acting CEO, Episurf Medical
Tel: +46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8.30 CET on 10 April 2017.